Xiaodong Xu

1.6k citations
59 papers · 1.2k indexed · h-index 18
Topics
Cancer-related molecular mechanisms research (7 papers)RNA modifications and cancer (4 papers)MicroRNA in disease regulation (4 papers)

In The Last Decade

Xiaodong Xu

55 papers receiving 1.2k citations

Peers

Xiaodong Xu
Comparison fields: 5 of 103
  • Molecular Biology 645
  • Oncology 273
  • Cancer Research 260
  • Immunology 214
  • Pulmonary and Respiratory Medicine 157
Replace Min Zheng with:
Min Zheng China
Wen Jiang China
Cuiling Qi China
Yanjun Guo China
Tadashi Uwagawa Japan
Hang Zheng China
Jianfei Gao China
Jing Ni China
Chao‐Wen Cheng Taiwan
Xiaodong Xu relative to Min Zheng China Min Zheng's profile →
Citations per field
00.5×1.5×1.8×
Min Zheng · 1×
Citations per year

Countries citing papers authored by Xiaodong Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaodong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodong Xu more than expected).

Fields of papers citing papers by Xiaodong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodong Xu. The network helps show where Xiaodong Xu may publish in the future.

Co-authorship network of co-authors of Xiaodong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodong Xu. A scholar is included among the top collaborators of Xiaodong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodong Xu. Xiaodong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 6
4 14
5 19
6 34
7 25
8 28
9 55
10 7
11 44
12 129
13 17
14 21
15 0
16 3
17 1
18 23
19
[The application of uncut Roux-en-Y esophagojejunostomy with distal jejunal pouch on behalf of the stomach surgery in the digestive tract reconstruction after total gastrectomy].
4
20 33

About Xiaodong Xu

Xiaodong Xu is a scholar working on Cancer Research, Hematology and Molecular Biology, having authored 59 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (260 citations), Immunology (214 citations) and Oncology (273 citations). Xiaodong Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Guoping Ding, Liping Cao, Shengnan Jia, Yan Chen, Tao Shen, Ningning Liang, Huiyong Yin, Luxiao Li, Zai‐yuan Ye and Youcheng Zhang. Their work appears in journals such as Circulation, The FASEB Journal and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026